Oryzon Expands Patent Protection For Iadademstat With Grant Decision In Mexico

March 12 (Reuters) - Oryzon Genomics SA ORY.MC:

• EXPANDS PATENT PROTECTION FOR IADADEMSTAT WITH GRANT DECISION IN MEXICO COVERING COMBINATIONS WITH PD-1/PD-L1 INHIBITORS

• MEXICAN PATENT OFFICE HAS ISSUED A DECISION TO GRANT FOR ITS PATENT APPLICATION ENTITLED "COMBINATIONS OF IADADEMSTAT FOR CANCER THERAPY"

• FOLLOWING FORMAL GRANT, THE PATENT IS EXPECTED TO PROVIDE PROTECTION UNTIL AT LEAST 2040

• ALLOWED CLAIMS PROTECT USE OF IADADEMSTAT IN COMBINATION WITH PD-1 OR PD-L1 INHIBITORS FOR TREATMENT OF CANCER, INCLUDING SMALL CELL LUNG CANCER

Source text